ClinicalTrials.gg
CompletedNCT06909084Updated Apr 3, 2025

Hearing Improvement After Making a Hole Surgically in Eardrum With or Without Ventilation Tube in Children With Glue Ears

An interventional study of Myringotomy with ventilation tube and Myringotomy alone in Otitis Media With Effusion in Children and Hearing Loss, sponsored by Allama Iqbal Teaching Hospital. Completed at 1 site in Pakistan. Open to participants aged 5 Years to 14 Years. Per ClinicalTrials.gov, last updated 2025-04-03.

Sponsored by Allama Iqbal Teaching Hospital · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 1 year 2 months after the study started (first participant enrolled Jan 2024, registered Mar 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
5 Years to 14 Years
Sex
All
01

Study summary

The goal of this clinical trial is to compare the effectiveness of myringotomy with ventilation tube insertion to myringotomy alone in improving hearing in children with glue ear.

The main question it aims to answer is:

Does adding a ventilation tube to myringotomy lead to greater improvement in hearing compared to myringotomy alone? Researchers will compare these two surgical techniques to determine which offers better outcomes for children with otitis media with effusion.

The Participants will:

  1. Have their hearing evaluated before surgery
  2. Undergo either myringotomy with ventilation tube insertion or myringotomy alone
  3. Have their hearing evaluated at follow-up visits at 2 weeks, 1 month, and 3 months post-operatively
02

Conditions studied

  • Otitis Media With Effusion in Children
  • Hearing Loss

Keywords

  • Otitis Media with Effusion
  • Hearing Loss
  • Children
  • Middle ear Ventilation
03

In context

Hearing Loss

796 studies on the registry are indexed under Hearing Loss; 193 are open to participants now.

This study's enrollment of 60 is above the median of 44 across 561 interventional studies indexed under Hearing Loss.

Browse Hearing Loss studies →

Lead sponsor

Allama Iqbal Teaching Hospital is the lead sponsor of 6 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
5 Years to 14 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • cases of otitis media with effusion
  • more than 20 decibel (dB) conductive hearing loss on pure tone audiometry
  • non-responder to medical treatment after three months of medical treatment

Exclusion criteria

Exclusion Criteria:

  • Children having recurrent otitis media
  • Discharging ears
  • History of bleeding disorder
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
60 participants (actual)

Study arms

  • Experimental
    Myringotomy with Ventilation tube

    A tympanostomy tube (Shepard tube) of appropriate size will be placed in the incision and canal will be packed with bismuth iodoform paraffin paste (BIPP)

    Procedure: Myringotomy with ventilation tube

  • Active comparator
    Myringotomy alone

    Incision in the eardrum (myringotomy) will be made. Middle ear canal will be cleaned after draining the fluid and the canal will be packed with bismuth iodoform paraffin paste (BIPP)

    Procedure: Myringotomy alone

Interventions

  • ProcedureMyringotomy with ventilation tube

    Under microscope tympanic membrane was visualized after cleaning the external auditory canal and myringotomy incision was given with the help of myringotome in anteroinferior quadrant of tympanic membrane. Secretions from middle ear were drained by suction. A tympanostomy tube (Shepard tube) of appropriate size was placed in the incision and canal was packed with bismuth iodoform paraffin paste which was removed after 24 hours.

  • ProcedureMyringotomy alone

    Under microscope tympanic membrane was visualized after cleaning the external auditory canal and myringotomy incision was given with the help of myringotome in anteroinferior quadrant of tympanic membrane. Secretions from middle ear were drained by suction. NO FURTHER PROCEDURE WAS DONE and canal was packed with bismuth iodoform paraffin paste which was removed after 24 hours.

06

What researchers measure

Primary outcomes

  1. Improvement in hearing

    The degree of hearing loss (dB) on pure tone audiometry was done before and after surgical procedure. Improvement in hearing level was labelled if there was decrease in hearing loss of 25% from baseline.

    Time frame: Before and Three months post operatively

Secondary outcomes

  1. Hearing Loss (dB)

    All patients underwent pure tone audiometry for assessment of hearing loss (dB)

    Time frame: Before and Three months post operatively

  2. Degree of Hearing Loss

    The degree of hearing loss (dB) on pure tone audiometry was done before and after surgical procedure. Degree of hearing loss was labelled as mild (20-40 dB), moderate (40-60 dB) and severe (60-80 dB).

    Time frame: Before and Three months post operatively

07

Study locations

1 site
  • Allama Iqbal Teaching Hospital Dera Ghazi Khan
    Dera Ghazi Khan, Punjab 32200, Pakistan
08

References and documents

Individual participant data

Plan to share: No — Individual participant data (IPD) might not be shared because it contains sensitive personal health information. Sharing such data could compromise participant confidentiality and privacy, and may conflict with ethical guidelines, informed consent, and regulatory requirements.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jan 2024 to primary completion in Sep 2024, 8 months.

Of 196 non-industry interventional studies with no phase under Hearing Loss, half reached primary completion within 31 months of starting (the median), counting those still running; a quarter within 14 and three quarters within 59. This study's 8 months is below that.

Counting every sponsor, half of 321 studies reached it within 19 months; a quarter within 5 and three quarters within 42.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 27, 2025
First posted
Apr 3, 2025
StartActual
Jan 1, 2024
Primary completionActual
Sep 30, 2024
CompletionActual
Dec 31, 2024
Last update
Apr 3, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 3, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06909084
Lead sponsor
Allama Iqbal Teaching Hospital
Responsible party
Dr. Mudasir Abbas (Principal Investigator, Allama Iqbal Teaching Hospital) — Principal investigator
First posted
Apr 3, 2025
Start date
Jan 1, 2024
Primary completion
Sep 30, 2024
Completion
Dec 31, 2024
Last update
Apr 3, 2025

Study contacts

Dr. Sharbaz Hussain Khosa, FCPS
study chair · Allama Iqbal Teaching Hospital Dera Ghazi Khan

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion